Leaflet BIMATOPROST ACCORD 0.1mg / ml ophthalmic drops solution

Product code:
W66190001
Quantity:
1
Indicated for:
glaucoma; ocular hypertension
Route of administration:
ophthalmic
Substance:
bimatoprost (glaucoma agent)
ATC
S01EE03 — Sensory organs | Antiglaucoma preparations and miotics | Prostaglandin analogues
Bimatoprost is a medication used to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It belongs to a class of drugs called prostaglandin analogs, which work by increasing the outflow of fluid from inside the eye, thereby lowering pressure.

The medication is available as eye drops and is typically administered once daily in the evening. It is important for patients to strictly follow their doctor's instructions to prevent vision deterioration.

Common side effects include eye redness, itching, burning sensation, and changes in iris color. In some cases, eyelash growth may occur, which some patients may consider a cosmetic benefit.

Bimatoprost is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about any other eye conditions or medications being used to avoid drug interactions.

General data about BIMATOPROST ACCORD 0.1mg / ml

Substance:
bimatoprost
Date of latest medicines list:
01-10-2019
Product code:
W66190001
Concentration:
0.1mg / ml
Pharmaceutical form:
ophthalmic drops solution
Quantity:
1
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
ACTAVIS GROUP PTC EHF. - ISLANDA
Holder:
ACCORD HEALTHCARE POLSKA SP. Z O.O. - POLONIA
Number:
8256/2015/01
Shelf life:
2 years-After packaging for sale;Dupa prima deschidere-4 weeks

Pharmaceutical forms available for bimatoprost

Concentrations available for bimatoprost

  • 0.1mg/g
  • 0.1mg/ml
  • 0.3mg/ml

Combinations with other substances